Khan, Kamran. “Efficacy and Safety of Sitagliptin, Metformin and Pioglitazone Fixed-Dose Combination Therapy (100 mg/1000mg and 15 Mg Respectively) As a First-Line Treatment in Obese Type 2 Diabetes With High Insulin Resistance”. International Journal of Medical and Biomedical Studies 9, no. 1 (February 27, 2025): 247–251. Accessed April 27, 2026. https://www.ijmbs.info/index.php/ijmbs/article/view/3064.